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Growth, survival and cytoskeletal rearrangement of cardiomyocytes are critical for cardiac hypertrophy. Signal 
transducer and activator of transcription-3 (STAT3) activation is an important cardioprotective factor associated 
with cardiac hypertrophy. Although STAT3 activation has been reported via signaling through Janus Kinase 2 
(JAK2) in several cardiac models of hypertrophy, the importance of other nonreceptor tyrosine kinases (NTKs) 
has not been explored. Utilizing an in vivo feline right ventricular pressure-overload (RVPO) model of 
hypertrophy, we demonstrate that in 48 h pressure-overload (PO) myocardium, STAT3 becomes phosphorylated 
and redistributed to detergent-insoluble fractions with no accompanying JAK2 activation. PO also caused 
increased levels of phosphorylated STAT3 in both cytoplasmic and nuclear fractions. To investigate the role of 
other NTKs, we used our established in vitro cell culture model of hypertrophy where adult feline 
cardiomyocytes are embedded three-dimensionally (3D) in type-I collagen and stimulated with an integrin 
binding peptide containing an Arg-Gly-Asp (RGD) motif that we have previously shown to recapitulate the focal 
adhesion complex (FAC) formation of 48 h RVPO. RGD stimulation of adult cardiomyocytes in vitro caused both 
STAT3 redistribution and activation that were accompanied by the activation and redistribution of c-Src and the 
TEC family kinase, BMX, but not JAK2. However, infection with dominant negative c-Src adenovirus was unable 
to block RGD-stimulated changes on either STAT3 or BMX. Further analysis in vivo in 48 h PO myocardium 
showed the presence of both STAT3 and BMX in the detergent-insoluble fraction with their complex formation 
and phosphorylation. Therefore, these studies indicate a novel mechanism of BMX-mediated STAT3 activation 
within a PO model of cardiac hypertrophy that might contribute to cardiomyocyte growth and survival. 
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Introduction 
Cardiac hypertrophy begins as a compensatory 
phenomenon when hemodynamic load to the heart 
increases. Terminally differentiated adult cardiac 
muscle cells, or cardiomyocytes, respond to 
mechanical load by increasing their mass through 
hypertrophy, although the mechanism that couples 
load to growth in the hypertrophied heart is not 
completely understood. Studies show that during 
mechanical loading of the heart, such as 
pressure-overload (PO), stretch-mediated changes[1] 
and adhesion-mediated changes[2] transduce 
biochemical signals into the cell. In this context, 
protein tyrosine phosphorylation of various 
intracellular substrates is critical for hypertrophic 
growth, and studies in various cell types have shown 
that integrin activation and focal adhesion complex 
(FAC) formation can mediate a transmembrane 
hierarchy of molecular responses,[2] including 
recruitment and activation of non-receptor tyrosine 
kinases (NTKs). Therefore, assembly and activation of 
NTKs at the FAC are critical for multiple downstream 
phenomena in virtually all cell types, including 
cardiomyocytes.  
  Our earlier studies,[3-5] using both in vivo 
pressure-overload (PO) and in vitro three-dimensional 
collagen matrix (3D) models, indicate the association 
of NTKs, including c-Src and FAK (focal adhesion 
kinase), ß3-integrin and several adaptor proteins with 
the detergent-insoluble actin-rich cardiac cytoskeletal 
(CSK) fraction. This process was found to be 
accompanied by tyrosine phosphorylation (PY) of 
several CSK-associated proteins. Although STATs are Int. J. Biol. Sci. 2008, 4 
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known to play critical roles as transcription factors for 
regulating cell proliferation and survival,[6] recent 
studies have identified other roles, including 
association at FAC and cell-cell junctions that may 
contribute to cell motility via alteration in adhesions 
and/or the cytoskeleton.[7-10] Of the six different 
STATs reported in humans, STAT3 is found to be 
widely expressed and also known to prevent apoptosis 
in different cell types.[11] STAT3 has become a recent 
focus of interest in cardiac research since its activation 
has been demonstrated during hypertrophy.[12, 13] 
Indeed, cardiac-restricted STAT3 knockout in mice[14, 
15] implicated its importance to cardiac physiology as 
deletion leads to several detrimental effects, including 
increased sensitivity to injury, decreased LV capillary 
formation, increased fibrosis, and decreased contractile 
function. Moreover, there is evidence that activated 
STAT3 provides cardioprotection from ischemic 
reperfusion injury in vivo.[16] Therefore, studies on the 
activation of STAT3 in the stressed heart are important 
for understanding its crucial role to the normal 
functioning of the heart. 
 
  Since we have established activation of several 
NTKs both in our in vivo PO model and in vitro cell 
culture model, we explored in the present study both 
STAT3 activation and the importance of upstream 
NTKs using these models. Tyrosine phosphorylation 
of STAT3 by NTKs is critical for the activation of 
STAT3.[6, 17] Moreover, this phosphorylation may 
help direct STAT3 to particular subcellular locations 
including endosomal compartments,[18] 
cytoskeleton,[8, 9] microtubules,[10] and nucleus[19] 
which influences its function. A major upstream kinase 
known to phosphorylate STAT3 during 
cytokine/growth factor stimulation is Janus kinase-2 
(JAK2).[6] However, c-Src can also mediate tyrosine 
phosphorylation of STAT3.[20] Similarly, another 
NTK, BMX (bone marrow tyrosine kinase in 
chromosome X), a member of the TEC family,[21, 22] 
has been shown to phosphorylate and activate STAT3 
in multiple cell types.[21, 23-25] BMX has a wide 
expression profile but has a particularly high 
expression in the heart and plays a broad role in cell 
signaling.[21, 22] Specifically, during nitric oxide 
generation in the heart, BMX activation via PKCε 
provides cardioprotection.[26] Furthermore, both 
BMX[27] and STAT3[14, 15] also contribute to 
myocardial vascular growth following ischemic 
preconditioning of the heart. Our present studies 
indicate a novel mechanism of activation and 
redistribution of STAT3 in PO myocardium with the 
involvement of integrin-mediated BMX activation. 
Materials and Methods 
Animal Model 
  Adult male cats weighing 2.8-3.5 kg were used 
for right ventricular PO by partial occlusion of the 
pulmonary artery, as we described previously,[28, 29] 
which results in systemic arterial pressure remaining 
stable while the pulmonary arterial pressure at least 
doubles. As such, the left ventricles serve as internal 
controls. We relied on two methods for achieving PO 
depending on desired duration. For short term PO (4 
h), cats underwent balloon-tipped catheter placement 
through the jugular vein under full surgical anesthesia. 
Long term PO (48 h and 1 wk) was achieved via 
placement of an external band using a 3.2 mm internal 
diameter band. Anesthesia was similar to that of the 4 
h cats, except that the animals were allowed to recover 
following anesthesia. These cats were later 
anesthetized again and sacrificed at the specified times 
and processed as for short term PO.  
Control cats (for both external banding and 
ballooning) were sham-operated by thoracotomy and 
pericardiotomy without arterial occlusion. The care of 
the animals and all experiments were conducted in 
accordance with the US National Institute of Health 
guidelines for the Care and Use of Laboratory Animals 
(NIH Publication No. 85-23, revised 1996) and the 
Institutional Animal Care and Use Committee of the 
Medical University of South Carolina. 
Adult Cardiomyocyte Cell Culture Models 
 The isolation of adult feline cardiomyocytes and 
culture on laminin-coated plates have been described 
previously.[30] Three-dimensional (3D) embedding of 
adult cardiomyocytes and integrin stimulation with 
RGD peptide were carried out as we described 
previously.[3, 4] Briefly, freshly isolated adult feline 
cardiomyocytes (1.25 x 105) were suspended in Piper’s 
medium prepared in M199 cell culture medium 
(GIBCO-BRL, Inc., Grand Island, NY) that contains the 
following: 2% bovine serum albumin (BSA), 5 mM 
creatine (Sigma), 2 mM L-carnitine (Sigma), 5 mM 
taurine (Sigma-Aldrich), 0.25 mM L-ascorbate 
(Sigma-Aldrich), 10 μM AraC, 40 nM insulin 
(GIBCO-BRL), 200 units/ml penicillin and 200 μg/ml 
streptomycin (GIBCO-BRL). While maintaining the pH 
at 7.4, suspended cells were mixed with soluble type-I 
collagen (Cohesion, Palo Alto, CA) at room 
temperature to a final volume of 2.5 ml/well in 8-well 
plastic dishes (Falcon) at a final collagen concentration 
of 0.1%. The cell-collagen mixture was allowed to 
polymerize by incubating at 37oC for 10 min in 
humidified 5% CO2 atmosphere, then covered with 0.5 
ml of M199 and incubated for an additional 50 min. For 
experiments using RGD peptide (Sigma), stock Int. J. Biol. Sci. 2008, 4 
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solutions of RGD peptide (Gly-Arg-Gly-Asp-Ser) were 
prepared in M199 and added to the cell-collagen 
mixture prior to polymerization at concentrations as 
indicated in the figures. To recover cardiomyocytes 
from collagen gels, 7.5 ml of collagenase-D (Boehringer 
Mannheim GmbH, Germany) prepared in Krebs 
solution at a concentration of 4 mg/ml was added to 
the gel matrix and incubated for 12 min in a shaking 
37oC water bath. The digested material was then 
centrifuged, and cells were subsequently washed two 
times with Krebs solution containing 0.1% BSA and 
once with phosphate buffered saline (PBS).  
Generation of c-Src Adenoviral Constructs and 
their Expression in Adult Cardiomyocytes 
  The generation of adenoviral constructs was 
based on He’s pAdEasy-1 system[31] as described 
previously.[3] Briefly, dominant negative c-Src cDNA 
(K295R, Y527F) was obtained from Upstate 
Biotechnology as a cloning vector and subcloned into 
the cloning vector, pSP72 (GIBCO-BRL). The c-Src 
restriction fragments were gel purified (Qiagen) and 
ligated into the adenoviral shuttle vector, 
pAdTrack-CMV, and cultured in LB agar with 
kanamycin. Positive clones were selected and screened 
by PCR using insert specific primers followed by 
propagation and DNA sequencing. The 
pAdTrack-CMV shuttle vectors were linearized using 
PmeI (New England Biolabs), gel purified, and 
recombined with the adenoviral genome plasmid with 
ampicillin resistance, pAdEasy-1, in competent BJ5183 
cells and plated on kanamycin plates. Positive clones 
were selected by an initial PCR screen for the insert 
and propagated for restriction enzyme analysis. 
Selected clones were transformed into DH5α cells, 
maxiprepped, and linearized with PacI. Following 
phenol-chloroform extraction, the adenoviral plasmids 
were transfected into HEK293 cells for packaging of 
the replication-defective adenovirus. After two plaque 
purifications, the virus titers were calculated. 
  Adenoviruses were used to infect isolated adult 
feline cardiomyocytes at an MOI of 10. Approximately 
5x105 c e l l s  w e r e  p l a t e d  o n  l a m i n i n - c o a t e d  1 0 0  m m  
d i s h e s  w i t h  1 0  m l  o f  P i p e r ’ s  m e d i a .  A f t e r  4  h  o f  
incubation at 37oC and 5% CO2, the media was 
changed to one containing a viral dose based on 
titration calculations. After 4-16 h of incubation, the 
virus media was removed and replaced with the same 
volume of media without virus. After 48 h of 
incubation, with one media change at 24 h, the cells 
were then washed with M199 twice and dead cells (if 
any) were removed with mild trypsinization (3.5 ml 
M199+600 μl of 0.25% trypsin/EDTA) for 5 minutes at 
37oC. The viable cardiomyocytes were then isolated 
using 2.5 ml M199 and 1 ml of 0.25% trypsin/EDTA 
treatment for 5 min at 37oC and 5% CO2. An additional 
1 ml of 0.25% trypsin/EDTA was then added every 5 
min until all of the cells were suspended. 10 ml Piper’s 
media was then added to quench the reaction. The 
cells were then pelleted with mild centrifugation and 
resuspended in 250 μl Piper’s medium for subsequent 
collagen gel studies as described above.  
Preparation of Tissue and Cell Lysates 
 For tissue lysates, the following preparation was 
performed. Felines that were surgically anesthetized 
had the hearts removed. The aortas underwent 
cannulation and retrograde flushing using ice-cold 
PBS. The heart was then separated into LV and RV 
tissue for immediate processing. For the preparation of 
tissue extracts, approximately 100 mg of tissue (~1.25 x 
105) was homogenized in a Tekmar Tissuemizer 
(Tekmar Co., Cincinnatti, OH) in 2 ml of Triton X-100 
extraction buffer (30 mM Tris-HCl, pH 7.4, 2% Triton 
X-100), containing Sigma protease inhibitor cocktail (P 
8340) and phosphatase inhibitor cocktails I and II 
(P2850 and P5726). Triton X-100 soluble and insoluble 
components were prepared as described previously. 
[3-5] Briefly, the homogenate was centrifuged at 16,000 
x g for 10 min to obtain a pellet and supernatant. The 
pellet was washed once by resuspending in 1 ml of 
Triton X-100 extraction buffer and then repeating the 
centrifugation (16,000 x g) step. The resulting pellet 
was mixed with 500 μl of SDS-sample buffer, boiled for 
3 min and centrifuged briefly (16,000 x g) at room 
temperature to obtain the Triton X-100-insoluble 
cytoskeletal proteins (CSK). The supernatant from the 
first spin underwent an additional centrifugation at 
100,000 x g for 2.5 h, and the pellet was resuspended in 
1 ml of SDS-sample buffer and boiled for 3 min to 
obtain Triton X-100-insoluble membrane skeletal 
proteins (MSK). Finally, the 100,000 x g supernatant 
(detergent soluble fraction) was mixed with equal 
volume 2x SDS-sample buffer, boiled for 3 min and 
used as Triton X-100 soluble (Sol) fraction.  
For lysates from collagen-embedded cells, a 
similar approach was taken but with slight 
modification because these cell lysates did not produce 
an MSK pellet on high-speed spin.[3-5] Harvested cells 
from collagen gels were homogenized in 0.3 ml of 
extraction buffer using a 26 G needle syringe and kept 
on ice for 10 min. This extract was centrifuged at 16,000 
x g for 10 min to obtain a pellet and supernatant. The 
pellet was washed once by resuspending in 0.5 ml of 
Triton X-100 extraction buffer and then repeating the 
centrifugation (16,000 x g) step. The resulting Triton 
X-100-insoluble pellet was mixed with 300 μl of 2x 
SDS-sample buffer, boiled for 3 min and centrifuged 
briefly (16,000 x g) at room temperature to obtain 
Triton X-100-insoluble proteins. Our previous studies Int. J. Biol. Sci. 2008, 4 
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indicate that this fraction is found to contain both the 
CSK and most of the MSK proteins.[3-5] The 
supernatant from first spin (which does not yield any 
pellet at high-speed spin) represents the Triton X-100 
soluble fraction and was prepared for Western blotting 
by adding equal volumes of 2x SDS-sample buffer, 
boiled for 3 min and used as detergent soluble (Sol) 
fraction. 
Nuclear Isolation 
  Nuclear isolation for the detection of 
STAT3/P-STAT3 was performed per manufacturer’s 
protocol with Nuclear and Cytoplasmic Extraction Kit 
(NE-PER, Pierce) with minor modifications. Briefly, 50 
mg ventricular tissue was homogenized using Tekmar 
Tissuemizer for 45 s in 1 ml PBS with protease and 
phosphatase inhibitor cocktails (Sigma). The 
homogenate was centrifuged at 1000 x g for 8 min. To 
the pellet, 500 μl of cytoplasmic extraction buffer I 
(CERI) with inhibitors was added. After suspending 
the pellet, the solution was incubated on ice for 15 min, 
followed by the addition of 27 μl CERII. The contents 
were incubated on ice for 2 min, centrifuged at 16,000 x 
g for 15 min, and the supernatant (cytoplasmic 
proteins) was mixed with equal volume of 2X 
SDS-sample buffer. The pellet was washed with PBS, 
suspended in 250 μl of nuclear extraction buffer with 
inhibitors and incubated on ice for 40 min with 
occasional vortexing. After centrifugation at 16,000 x g 
for 15 min, the supernatant, consisting of nuclear 
proteins, was mixed with equal volume of 2X SDS 
sample buffer. 
Immunoblotting 
  Subfractioned protein samples in SDS sample 
buffer were resolved by SDS-PAGE and 
immunoblotted as previously described.[3, 4] Primary 
antibodies used were: polyclonal antibodies for 
STAT3, phospho-STAT3, phospho-Etk (BMX) and 
monoclonal phosphotyrosine 416 Src (Cell Signaling 
Technology); monoclonal antibodies for BMX, and 
phosphotyrosine (BD Biosciences); monoclonal 
antibody for c-Src and polyclonal antibodies for JAK2, 
phospho-JAK2, and histone H4 (Upstate 
Biotechnology, Inc); polyclonal anti-actin antibody 
(Sigma); polyclonal antibody for 
glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) (Research Diagnostics Inc). To normalize 
protein concentration between LV and RV pairs, 
GAPDH (Triton-soluble and cytoplasmic), actin 
(Triton-insoluble), and histone-H4 (nuclear) levels 
were measured. For denstitometric quantitation, NIH 
ImageJ v. 1.34r was used.  
Immunoprecipitation of STAT3-BMX Complex 
  Membrane skeletal (MSK) pellets obtained from 
ventricular tissue were solubilized in modified 
radioimmunoprecipitation assay (mRIPA) buffer 
(containing: 50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.25% 
sodium deoxycholate, 150 mM NaCl, 0.1% sodium 
dodecyl sulfate and protease and phosphatase 
inhibitors as mentioned previously) and briefly 
sonicated. The resulting solution was rotated with 
STAT3 antibody for 2 h at 4oC followed by rotation 
with Protein A/G beads (Santa Cruz) for 1 h at 4oC. 
The beads were then washed with mRIPA buffer 
thrice, boiled with 1X SDS sample buffer and used for 
Western blot analysis as described earlier.[3, 4] As 
controls, we rotated either the lysates with Protein 
A/G beads in the absence of STAT3 antibody or the 
buffer with Protein A/G beads in the presence of 
STAT3 antibody. 
Two-dimensional (2D) Gel Electrophoresis 
  SDS-sample buffer boiled samples (Triton X-100 
soluble and insoluble MSK proteins) were processed 
using Proteome Systems reagents/protocol except for 
minor modifications as follows. 250 μl of C7 detergent 
solution was added to 500 μl of Triton X-100 soluble or 
insoluble fractions. After mixing, 100 μl of this solution 
was added to 900 μl acetone, and placed on ice for 1 h. 
Samples were centrifuged for 10 min at 5000 rpm, and 
the pellet was washed twice in 75% acetone. The pellet 
was air-dried for 15 min and 1 ml of C7 reagent, and 40 
μl of Tris-base solution were added to the protein 
pellet. Following sample solubilization, 50 μl of 
tributylphosphine (Sigma) and 20 μl of alkylation 
agent (Proteome Systems) were added and samples 
were incubated at room temperature for 90 min with 
occasional vortexing. 10 μl of quenching reagent was 
then added and samples were centrifuged for 5 min at 
5000 rpm to pellet insoluble material. Supernatant was 
then aliquoted for subsequent 2D analysis.  
For 2D gel electrophoresis, 11 cm IPG strips were 
re-hydrated with 200 μl of the aliquoted sample at 
37°C for 6 h. Strips were then subjected to 1st 
dimension electrophoresis using the following 
parameters: 100V-2 h; 100-1000V 3 h; 1000V-2 h; 
1000-8000V-1 h; 8000V-10 h; 8000-2000V-1 h; 
2000V-hold until processed. Strips were then placed on 
top of 6-12% Tris-acetate gels and electrophoresed for 2 
h at 200V. Proteins from gels were transferred onto 
Immobilon-P membranes and immunoblotted as 
described above.   
Statistics 
  Data are expressed as means +/-SEM. Statistical 
comparisons were made by one-way ANOVA Int. J. Biol. Sci. 2008, 4 
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followed by either Bonferroni or Tukey post hoc 
analysis. Failed normality or equal variance tests were 
followed by Kruskal-Wallis one way analysis of 
variance and Dunn’s method for multiple comparisons 
to control groups (SigmaStat 3.5, Systat Software, Inc., 
San Jose, CA). A p-value < 0.05 was considered 
statistically significant. 
Results 
Temporal/spatial Relationship of STAT3 and 
Phosphorylated STAT3 within RVPO and 
RGD-stimulated 3D Collagen Models 
  We initially examined whether STAT3 becomes 
activated in our established feline right ventricular 
pressure-overload (RVPO) model[28-30, 32] in which 
the pulmonary artery is partially occluded to increase 
RV wall stress. The left ventricle (LV) remains 
normally loaded and is used as an internal control. 
Table 1 shows the hemodynamic data for this model. 
For biochemical analyses, we utilized two independent 
cell fractionation techniques: one fractionates proteins 
based on their detergent solubility, and the second 
fractionates nuclear proteins. In the first, we process 
tissue samples to obtain both Triton X-100 soluble 
fraction (which consists of all nonionic-detergent 
soluble proteins including those in the nucleus) and 
the insoluble fractions, obtained after low-speed 
(cytoskeleton pellet; CSK) and high-speed (membrane 
skeleton pellet; MSK) centrifugation. These Triton 
X-100 insoluble pellet samples (CSK and MSK) do not 
include Triton X-100 insoluble "raft-floatation" 
materials. The second protocol was primarily used to 
isolate nuclear proteins by lysing tissue or cell samples 
in a detergent-free buffer provided by the nuclear 
isolation kit. 
Table 1. Hemodynamic characteristics of RVPO felines 
 
 
Analysis using detergent-lysed subfractions from 
both sham-operated control and RVPO cats for various 
time periods indicate STAT3 recruitment to MSK and 
to (a lesser extent) CSK fractions in 48 h 
pressure-overloaded RV (Figure 1a, left panel). 
Furthermore, increased tyrosine phosphorylation of 
STAT3 (P-STAT3) at Tyr705 (indicating activation) was 
detected in all three (soluble, CSK, and MSK) fractions 
of pressure-overloaded RV, when compared to 
normally loaded LV subfractions (right panel), 
although it was higher in Triton X-100 soluble and 
insoluble MSK fractions when compared to CSK 
fraction. These changes observed in 48 h RVPO cats 
were significant (Figure 1a, bottom panels) (p<0.05) 
and were not due to intrinsic differences between RV 
and LV based on the observation in sham control cats. 
By 1 wk RVPO, both STAT3 recruitment and 
phosphorylation were substantially reduced. 
Therefore, STAT3 undergoes a transient activation and 
recruitment to the detergent insoluble structures 
during PO. 
Since Tyr705 phosphorylation of STAT3 is 
indicative of its activation,[6, 8, 18, 19] we wanted to 
determine whether phosphorylated STAT3 is present 
in the nucleus for transcriptional activation. Therefore, 
we analyzed both sham control and 48 h RVPO felines 
for STAT3 translocation to the nucleus (Figure 1b). For 
this, LV and RV tissue from these cats were processed 
to obtain cytoplasmic and nuclear fractions (Figure 1b, 
top panels). The levels of GAPDH and histone-H4 
show equal protein loading in each set of samples in 
the cytoplasmic and nuclear fractions, respectively. In 
sham control cat ventricles, STAT3 was predominantly 
cytoplasmic and P-STAT3 was barely detectable. In 48 
RVPO cats, the levels of STAT3 and P-STAT3 in 
normally loaded LV control were similar to sham 
control cats, but the RV exhibited a substantial increase 
in STAT3 levels in both cytoplasmic and nuclear 
fractions. Interestingly, both cytoplasmic and nuclear 
STAT3 showed significant increases in 
phosphorylation showing activation in both locations. 
Quantification (Figure 1b, middle panels) revealed that 
the RV to LV ratios of both STAT3 and P-STAT3 in the Int. J. Biol. Sci. 2008, 4 
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cytosolic and nuclear fractions of 48 h RVPO cats are 
significantly (p<0.05) increased compared to sham 
controls. However, analysis of the distribution of 
STAT3 and P-STAT3 in the cytoplasmic/nuclear pools 
shows that 25-30% of STAT3 (total or phosphorylated) 
is present in the nucleus of control heart and that this 
distribution is not altered during pressure overload 
(Figure 1b, bottom panel). 
We next determined whether STAT3 activation 
specifically occurs upon integrin activation. For this, 
adult feline cardiomyocytes were embedded in a 3D 
collagen matrix and treated with RGD peptide.[3, 4] In 
this model, our previous work[3] demonstrated that 
subfractionation of the detergent-lysed homogenate of 
cardiomyocytes during differential centrifugation 
yields only the low-spin pellet and corresponds to 
CSK, while additional high-speed centrifugation does 
not yield a second pellet (MSK) as seen in ventricular 
tissue samples. However, we do find many of the MSK 
proteins in the CSK fraction obtained during 
low-speed centrifugation.[3] In the present in vitro 
studies, analysis of the detergent soluble and 
insoluble-pellet (CSK+MSK) fractions revealed that 
STAT3 was predominantly present in the detergent 
soluble fraction under normal conditions (Figure 1c, 
top panel), similar to what was observed in in vivo 
control tissue. However, upon RGD stimulation in this 
3D model, STAT3 was recruited to the insoluble pellet 
fraction and P-STAT3 levels were increased both in the 
insoluble and soluble fractions (p<0.05). Overall, 
experiments shown in Figure 1 indicate that in PO 
myocardium STAT3 and P-STAT3 levels are increased 
in the cytoplasmic and nuclear fractions, that P-STAT3 
is recruited to the Triton X-100 insoluble pellet 
fractions and that this observation could be mimicked 
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Figure 1. STAT3 localization and activation in RVPO felines and integrin-stimulated cardiomyocytes: (a) LV and RV from sham 
control and 4 h, 48 h and 1 wk RVPO felines were processed for cytoskeleton (CSK), membrane skeleton (MSK) and soluble (Sol) 
fractions. Protein concentrations between LV and RV pairs for each fraction were adjusted based on GAPDH (Soluble) and actin 
(Insoluble) contents (data not shown). The left panel shows immunoblots for total STAT3 while the right shows corresponding 
Tyr705 phosphorylated STAT3 (P-STAT3) blot. Quantitation of four sham control and five 48 h RVPO felines are shown (bottom 
panel). RV to LV densitometry ratios for each detergent-lysed subfraction was dilution-normalized and are shown. (b) LV and RV 
tissues from sham control and 48 h RVPO felines were processed for cytoplasmic and nuclear fractions. Immunoblots were 
performed using STAT3, P-STAT3, GAPDH (cytoplasmic marker), and histone-H4 (nuclear marker) antibodies. Four sham control 
and four 48 h RVPO feline samples were analyzed for STAT3 and P-STAT3 and normalized by GAPDH (cytoplasm samples) or 
histone-H4 (nuclear samples) levels. RV to LV ratios for each subfraction were plotted for control vs. 48 h RVPO (Middle Panels). 
In addition, percentage distribution of cytoplasmic vs. nuclear localization was plotted for each condition (Lower Panels). (c) Adult 
feline cardiomyocytes embedded within a 3D collagen matrix in the presence or absence of 9 mM RGD peptide for 1 h were 
extracted with Triton X-100 buffer and soluble (Sol) and insoluble (Insol) fractions were prepared for immunoblotting of STAT3 and 
P-STAT3. Densitometry from four independent experiments (bottom panel) was performed and ratios of RV/LV are plotted for (a) 
and (b) while for (c), STAT3 level in Sol fraction of control was arbitrarily set at 100. The mean +/- SEM is plotted for each. * p < 
0.05 compared to corresponding controls. 
STAT3 Activation in both RVPO in vivo and RGD 
Stimulation in vitro is not Accompanied by JAK2 
Activation 
  To ascertain whether the classic JAK2-mediated 
pathway is involved during STAT3 activation, we 
assayed for JAK2 recruitment to the insoluble fraction 
and phosphorylation at Tyr1007/1008 sites at all time 
points of PO (Figure 2a) and RGD stimulation of 
cardiomyocytes (Figure 2b). However, neither RVPO 
nor RGD stimulation of adult cardiomyocytes 
exhibited JAK2 recruitment or phosphorylation. We 
confirmed our data using an additional commercially 
available antibody for the detection of JAK2 
phosphorylation at Tyr1007/1008 sites (data not 
shown). To test the antibody specificity for feline 
samples, we stimulated adult feline cardiomyocytes 
c u l t u r e d  o n  l a m i n i n - c o a t e d  d i s h e s  w i t h  E G F .  T h e s e  
experiments showed JAK2 phosphorylation upon EGF 
stimulation (Figure 2c), indicating the possibility that a 
JAK2-independent mechanism contributes to STAT3 




Figure 2. Analysis of JAK2 in PO myocardium and 
RGD-treated cardiomyocytes: Ventricular tissue samples and 
cardiomyocytes in 3D collagen matrix were processed to obtain 
detergent-lysed subfractions, and protein concentrations were 
adjusted. (a) Left column shows JAK2 immunoblots in the 
detergent-lysed subfractions at various times of RVPO while the 
right column shows the corresponding 
Tyr1007/1008-phosphorylated JAK2 (P-JAK2). (b) Top panel 
shows JAK2 immunoblots in soluble (Sol), and insoluble 
(CSK+MSK) fractions prepared from control and 
RGD-stimulated cardiomyocytes. Bottom panel shows the 
corresponding P-JAK2 immunoblot. Results of (a) and (b) were 
confirmed at least twice. (c) Positive control where adult feline 
cardiomyocytes cultured on laminin-coated plates were treated 
with 30 nM EGF for 10 and 30 min, and the soluble extract was 
used for JAK2 (top panel) and P-JAK2 (bottom panel) 
immunoblots. 
 
STAT3 Activation is Independent of c-Src 
Activation 
  We next analyzed whether c-Src, a Src family 
NTK, was responsible for STAT3 
phosphorylation/activation. In 48 h PO tissue samples, 
c-Src was active in all detergent-lysed subfractions, as 
indicated by its Tyr416 phosphorylation (Figure 3a, 
lower panel) and in addition, c-Src recruitment to the 
CSK (upper panel). We then sought to link c-Src and 
STAT3 in our 3D model through the adenoviral 
expression of a dominant negative form of c-Src 
(DNSrc). The DNSrc was created by double mutations 
(K295R/Y527F) where the lysine mutation causes loss 
of the ATP transfer site to render the kinase inactive, 
while the tyrosine mutation favors c-Src's 
open/inactive conformation. This well characterized 
mutant will retain adaptor function while losing 
kinase activity.[33, 34] At an MOI of 10, DNSrc 
expression was >20 fold higher over endogenous c-Src 
(Figure 3b, upper panels), and RGD stimulation of 
cardiomyocytes still resulted in recruitment of DNSrc 
to the detergent insoluble fraction (Figure 3b upper 
panels) but only minimally impacted overall tyrosine 
phosphorylation level of proteins compared to control 
(Figure 3b, lower panels). Indeed, the upper most 
arrow shows the position of actin. The middle arrow 
indicates a phosphorylated protein band that exhibited 
enhanced phosphorylation during RGD-stimulation 
and seems to be dependent on c-Src activation as it is 
greatly diminished upon inclusion of DNSrc. 
However, the lowest arrow exhibits a protein that has 
no dependence on c-Src activation, as its 
RGD-stimulated phosphorylation in the presence of 
DNSrc is unchanged from control cells. Together these 
data suggest that RGD stimulates c-Src dependent and 
independent tyrosine phosphorylation of cellular 
proteins. When we examined STAT3 under these 
conditions (Figure 3c), both RGD-stimulated 
recruitment to the insoluble fraction and 
phosphorylation of STAT3 were unaffected by DNSrc 
overexpression. These results indicate that the kinase 
function of c-Src does not contribute to STAT3 
phosphorylation in PO myocardium in vivo or 
RGD-stimulated adult cardiomyocytes in in vitro.  
 
Membrane Skeletal Redistribution and 
Phosphorylation/activation of BMX in PO 
Myocardium 
  We next tested if members of the TEC family 
NTKs serve as upstream kinases for the STAT3 
phosphorylation. Results shown in Figure 4a 
demonstrate that BMX levels in 48 h PO RV were 
markedly increased in the soluble fraction compared 
to same animal control LV. Importantly, a substantial 
amount of BMX was also recruited to the MSK, similar 
to STAT3 (Figure 1). However, by 1 wk PO 
myocardium, BMX level in the MSK was almost 
undetectable. The summary data, comparing BMX in 
control and 48 h RVPO felines (Figure 4a, right panel), 
show that BMX is predominantly present in the soluble 
fraction, and 48 h PO causes a dramatic increase (p < 
0.05) both in the soluble (2.5 fold) and MSK (13 fold) 
fractions. Finally, we analyzed 48 h PO tissue for other 
TEC family members for their expression and 
distribution in PO myocardium (Figure 4b). These 
studies indicate that only BMX and TEC are expressed 
in the heart, although, unlike BMX, TEC did not show 
any change in expression or distribution during PO 
(Figure 4b). Int. J. Biol. Sci. 2008, 4 
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  To confirm BMX activation, we explored its 
phosphorylation state in both detergent soluble and 
MSK fractions, since autophosphorylation on a specific 
tyrosine residue in the catalytic domain is critical for 
its kinase activity.[21] We performed two-dimensional 
(2D) gel electrophoresis (Figure 4c) of soluble and MSK 
fractions as commercial antibodies were not suitable 
for immunoprecipitation using feline 
detergent-insoluble fractions. BMX was found to 
migrate in multiple spots both in the soluble fraction of 
normally loaded LV and in the soluble and MSK 
fractions of pressure-overloaded RV. However, only 
pressure-overloaded RV (both Sol and MSK) showed 
an increase in overall levels, consistent with the RVPO 
time course (Figure 4a), and a significant migration 
towards the positive electrode during isoelectric 
focusing, indicating hyperphosphorylation.  
To demonstrate whether these 
hyperphosphorylated spots have PY, we stripped and 
reprobed the membrane with phosphotyrosine 
antibody (Figure 4c bottom panels). These experiments 
indicate the presence of an increased level of 
phosphotyrosine in these hyperphosphorylated BMX 
spots in both soluble and MSK fractions of PO 
myocardium. To determine whether this process 
might be mediated via integrins, we analyzed our 
collagen model for BMX recruitment and activation. 
As shown in Figure 4d, BMX exhibits an RGD 
dose-dependent recruitment to the detergent insoluble 
fraction. Furthermore, 2D electrophoresis of the 
recruited BMX exhibited the characteristic pattern of 
hyperphosphorylation, including tyrosine 
phosphorylation (Figure 4e) as observed in PO tissue 
samples (Figure 4c).   
 
 
Figure 3. The effect of DNSrc overexpression on integrin-stimulated STAT3 redistribution and phosphorylation in cardiomyocytes: 
(a) Detergent-lysed subfractions were prepared from 48 h RVPO felines as in Figure 1a and analyzed for c-Src distribution and 
Tyr416 phosphorylation. (b) Adult feline cardiomyocytes cultured on laminin-coated dishes were infected with DNSrc adenovirus at 
MOI=10 for 36 h. Uninfected (Cont) and infected (DNSrc) cells were harvested and embedded in type-I collagen (3D environment) 
with or without 9 mM RGD. Detergent soluble and insoluble fractions of cardiomyocytes were prepared as in Figure 1c. 
Immunoblots show c-Src (top panel) and tyrosine phosphorylated protein (bottom panel) levels. The upper most arrow (open) in the 
tyrosine phosphorylation blot shows the band corresponding to actin, which was used for normalization. The middle (solid) and 
bottom arrows (diamond) indicate phosphorylated protein bands that are dependent and independent on RGD-stimulated c-Src 
activation, respectively. (c) Detergent soluble and insoluble fractions prepared as in (b) were used for STAT3 and anti-P-STAT3 
immunoblots. Results were confirmed thrice. 
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Figure 4. Localization and phosphorylation of BMX in Triton X-100 insoluble pellet fractions of both RVPO feline myocardium 
and integrin-stimulated cardiomyocytes: (a) Ventricular tissue samples from control and RVPO felines were processed to obtain 
detergent-lysed subfractions as in Figure 1a and used for anti-BMX immunoblotting. Six control and six 48 h RVPO felines were 
scanned and RV to LV ratios for each fraction of control and 48 h RVPO felines were determined and plotted. Values are the mean 
+/- SEM. * p < 0.05 compared to control. (b) Distribution of TEC family kinases in detergent-lysed subfraction of PO feline 
myocardium: LV and RV from a 48 h RVPO feline were processed to obtain Triton X-100 soluble (Sol) and insoluble cytoskeleton 
(CSK) and membrane skeleton (MSK) fractions. Samples were then used for Western blot analysis with anti-BMX, -TEC, -BTK and 
-ITK antibodies. (c) Two-dimensional gel electrophoresis of both soluble (Sol) and MSK fractions from 48 h RVPO felines was 
performed and immunoblotted with anti-BMX antibody (Top panel). To analyze tyrosine phosphorylation (PY) of BMX, blots were 
stripped and reprobed with phosphotyrosine antibody (bottom panel). Arrows indicate the position of phosphorylated BMX. Results 
were confirmed twice. (d) and (e) Adult cardiomyocytes were stimulated with RGD and detergent soluble and insoluble samples 
were prepared. (d) Immunoblot showing RGD dose response of BMX cellular redistribution. (e) Two-dimensional gel 
electrophoresis of control (Cont) and 9 mM RGD-stimulated detergent-insoluble (CSK+MSK) samples of collagen-embedded 
cardiomyocytes was performed with anti-BMX immunoblotting (Top panel). Blots were stripped and then reprobed for 
phosphotyrosine (bottom panel). Arrows indicate the position of phosphorylated BMX. The location of the + and – electrodes are 
indicated. Results were confirmed twice. 
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STAT3 and BMX are Complexed in vivo During 
PO 
  Finally, to demonstrate that PO induces BMX 
interaction with STAT3 in vivo and possibly serves as 
an upstream kinase, we gently solubilized the MSK 
fractions from control and PO felines with mRIPA 
buffer. Figure 5 shows STAT3 immunoprecipitation 
from MSK fractions of a control and two independent 
48 h RVPO felines. As expected, STAT3 levels were 
much higher in the pressure-overloaded RV MSK 
samples. When STAT3 immunoprecipitates were 
analyzed, BMX was found to be complexed with 
STAT3 only in PO RV samples. For control purposes, a 
“no antibody control" was performed simultaneously 
where MSK sample from pressure overloaded RV was 
mixed with protein A/G beads and processed with 
other samples. This negative control did not show the 
presence of either STAT3 or BMX, although the MSK 
sample used for this IP has both these proteins. In 
addition, inclusion of 2 μg of nonimmune IgG (rabbit) 
in our immunoprecipitation protocol with MSK 
sample of pressure overloaded RV showed no STAT3 
or BMX (data not shown). Finally, the bands seen in 
the Western blot for BMX and STAT3 could not be due 
to STAT3 antibody cross reaction, since normally 
loaded LV sample does not show such bands 
corresponding to BMX and STAT3. 
 
 
Figure 5. Co-immunoprecipitation of STAT3 and BMX: 
Ventricular tissue samples from sham control (Cont) or 48 h 
RVPO felines (two independent felines. PO#1 and PO#2) were 
processed to obtain MSK pellet. The pellet was re-suspended in 
mRIPA and immunoprecipitated with STAT3 antibody. 
Immunoprecipitates were used for anti-STAT3 and anti-BMX 
immunoblotting. Non-specific binding to agarose beads was 
ruled out by omitting STAT3 antibody during 
immunoprecipitation from RV extract (RV-Ab lane). 
 
Discussion  
STAT3 is an important transcription factor for 
cellular proliferation, differentiation and survival. 
Phosphorylation of STAT3 activates gene expression 
affecting cell-cell adhesion, growth/proliferation and 
has also been implicated during activation of 
anti-apoptotic Bcl proteins.[6] Although STAT proteins 
exist as dimers and tetramers in unphosphorylated 
states, phosphorylation is critical for monomer 
conformational changes that will allow for effective 
nuclear import, in the case of STAT1, and DNA 
binding based on crystal structure studies. In the 
unphosphorylated state, STAT1 is not recognized by 
importin-α5 because the unphosphorylated dimers 
mask the nuclear-localization signal. In contrast, 
despite sharing 70% homology with STAT1, STAT3 
does behave differently. STAT3 accumulates in the 
nucleus independent of phosphorylation state, mainly 
through direct nuclear translocation by importin-α3. 
However, this is a dynamic process in which STAT3 is 
shuttled into and out of the nucleus.[35] In fact, only a 
small fraction of non-phosphorylated STAT3 is found 
in the nucleus at any one time.[17] As such, it has been 
suggested that STAT3 phosphorylation can induce a 
STAT1/STAT3 heterodimer that has inducible nuclear 
transport allowing for increased nuclear 
accumulation.[19] Furthermore, recent studies[9, 35] 
show that prolonged phosphorylation of STAT3 
results in more sustained nuclear localization. Also, 
although there is some evidence for unphosphorylated 
STAT3 to influence the transcription of a small number 
of genes, phosphorylation of STAT3 is very important 
for the vast majority of gene regulation by STAT3. 
Thus, tyrosine phosphorylation of STAT3 promotes a 
particular homodimerization conformation involving 
its SH2 (Src-homology 2) domain enabling STAT3 to 
bind target genes during transcriptional activation, 
including pro-survival genes.[6]  
To study changes in STAT3 during cardiac 
hypertrophy, we initially utilized a RVPO model and 
analyzed both cellular distribution and 
phosphorylation of STAT3. Our studies demonstrate 
that STAT3 levels are significantly increased and 
redistributed to the MSK fraction in 48 h PO 
myocardium. In addition, STAT3 was significantly 
phosphorylated under these conditions in both 
detergent soluble and insoluble (CSK and MSK) 
fractions, and the level of P-STAT3 was increased in 
both nuclear and cytoplasmic fractions. Increased level 
of P-STAT3 in both the MSK and nucleus indicates a 
dual role of STAT3 in cytoskeletal remodeling and cell 
survival during PO hypertrophy, a model that has 
already been implicated in cancer.[8] Interestingly, a 
recent publication[9] has shown that STAT3 
phosphorylation in multicellular aggregates of 
squamous cell cancer cell lines begins as a diffuse 
cytoplasmic distribution and at cell-cell junctions at 
first with very little nuclear localization, but at later 
time points (12-24 h), P-STAT3 accumulates in the 
nucleus. As such, there appears to be a difference in Int. J. Biol. Sci. 2008, 4 
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the length of time that STAT3 remains phosphorylated 
based on the type of stimulus responsible for the 
phosphorylation. Indeed, cytokine stimulation of 
STAT3 phosphorylation is transient (~30 minutes). 
However, v-Src-transformation of NIH 3T3 cells 
results in constitutive STAT3 phosphorylation which is 
unaffected by JAK inhibitors.[36] A recent study[35] 
has suggested that the mechanism by which this 
occurs is through more rapid cycling of “activated” 
STAT3 between the nucleus and cytoplasm than 
“non-activated” STAT3. However, our studies indicate 
that the tyrosine phosphorylation of STAT3 in 48 h PO 
myocardium does not appear to be required for the 
increased level of STAT3 in the nucleus, since the 
distribution of STAT3 or P-STAT3 between cytoplasm 
and nucleus was not significantly altered in 48 h PO 
myocardium. 
  Tyrosine kinases that mediate STAT3 
phosphorylation include: (i) JAK kinases that function 
downstream of cytokines, (ii) other NTKs, such as 
c-Src and BMX, and (iii) growth factor receptor 
kinases, such as epidermal growth factor receptor. We 
have shown previously in vivo[4, 5] that PO can cause 
integrin activation, resulting in cytoskeletal assembly 
and activation of c-Src and FAK, and tyrosine 
phosphorylation of several cytoskeleton-bound 
proteins in 24-48 h PO myocardium. We were then 
able to reproduce this activation in 3D 
collagen-embedded cardiomyocytes stimulated with 
RGD peptide.[3, 4] Therefore, we utilized our 3D 
collagen model to demonstrate that integrin 
stimulation with RGD peptide causes STAT3 
activation/phosphorylation and to characterize the 
responsible upstream NTK(s). These studies suggest 
that our previously established integrin-mediated 
NTK activation and FAC formation[3, 4] may 
contribute to STAT3 activation in PO myocardium. In 
support of this, other recent studies[37, 38] also 
demonstrate integrin-mediated c-Src activation and 
FAC formation can contribute to STAT3 
phosphorylation/activation. Presence of STAT3 at 
FAC sites has been demonstrated previously[7] to 
enhance FAK activity.[39] Furthermore, evidence 
exists for STAT3 interaction with other components of 
the cytoskeleton, including paxillin, p130Cas, and 
stathmin.[10] Therefore, STAT3 presence in the MSK of 
48 h PO myocardium is indicative of its possible role at 
the FAC for cytoskeletal remodeling, independent of 
its transcriptional role. 
To identify the responsible kinases for STAT3 
phosphorylation, we explored the activation of 
potential upstream NTKs. Our analysis using in vivo 
and in vitro models of hypertrophic stimulation did not 
show JAK2 phosphorylation, though JAK2 
phosphorylation/activation could be observed in 
EGF-treated adult feline cardiomyocytes in vitro. An 
earlier study[40] in a murine transverse aortic 
constriction PO model demonstrates that STAT3 
undergoes biphasic acute (3 h) and hypertrophic 
responses (48 h) via the gp130-mediated JAK2 
signaling where the activated STAT3 plays an 
autoregulatory negative feedback role by promoting 
the expression of a JAK2 inhibitor protein, SOCS3 
(suppressor of cytokine signaling-3). Therefore, our 
studies in PO feline myocardium cannot rule out 
JAK2's contribution to STAT3 phosphorylation in the 
early period of PO,[41] where it might be subsequently 
inactivated by the expression of SOCS, and under 
these conditions, other NTKs might sustain STAT3 
activation. Indeed, it appears that STAT3 activation by 
non-JAK NTKs, such as v-Src, is not susceptible to 
SOCS overexpression.[36] 
A l t h o u g h  o u r  p r e v i o u s  w o r k  b o t h  i n  4 8  h  P O  
myocardium and in RGD-stimulated adult 
cardiomyocytes[3, 4] demonstrates c-Src recruitment 
and activation, expression of DNSrc in cardiomyocytes 
in the 3D environment did not affect the 
RGD-stimulated STAT3 phosphorylation. These data 
suggest that c-Src kinase activity is not critical for 
STAT3 phosphorylation, however, it is possible that 
c-Src may function as an adaptor to recruit other NTKs 
for STAT3 phosphorylation.   
 Finally, we focused on the possible role of a TEC 
family member, BMX, in STAT3 phosphorylation. 
BMX, which is highly expressed in the heart, may 
serve as an upstream kinase for STAT3 
phosphorylation as reported previously both in c-Src 
dependent[25] and independent[24] manners. Our 
studies on BMX in 48 h PO myocardium include: (i) 
overall increase of BMX, (ii) recruitment of a 
significant amount of BMX to the MSK as in the case of 
STAT3, (iii) hyperphosphorylation of MSK-bound 
BMX and (iv) the presence of a BMX/STAT3 complex 
in MSK. These transient changes were observed in 48 h 
PO myocardium but were absent in both 4 h and 1 wk 
P O  m y o c a r d i u m  a n d  c o r r e l a t e  w e l l  w i t h  S T A T 3  
activation and with our earlier observation in 48 h PO 
myocardium[4, 5] that showed integrin activation and 
FAC formation, consisting of NTKs. Whereas our 
previous studies show c-Src and FAK recruitment to 
the CSK fraction, we observe in the present study BMX 
recruitment to the MSK fraction similar to STAT3. 
Importantly, the increased level of BMX in Triton 
X-100 soluble and insoluble MSK fractions, relative to 
CSK fraction, correlates well with the increased levels 
of P-STAT3 in these fractions (Figure 1a). BMX is 
unique among tyrosine kinases in that it contains a 
pleckstrin homology (PH) domain that binds to Int. J. Biol. Sci. 2008, 4 
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specific phosphoinositides which may explain its MSK 
association. Although our studies[3-5] indicate that 
most focal adhesion proteins are found in the CSK 
fraction, it is not clear whether BMX and STAT3, which 
are complexed in the MSK fraction, are part of the focal 
adhesion or represent an independent localization in 
the cell. We were unable to resolve this issue 
confocally, since the commercially available BMX 
antibodies used in this study were not useful for 
confocal imaging in feline heart. Interestingly, several 
studies have localized STATs within lipid-rafts in 
connection with caveolins.[42] Furthermore, there is 
some evidence for BMX interacting with caveolin-1 in 
bone marrow cells.[43] It is therefore possible that the 
MSK-bound STAT3 and BMX in PO myocardium are 
localized to caveolae. 
Our studies with adult cardiomyocytes in vitro 
demonstrate that in a 3D model, but not in a 2D model 
without FAC formation (data not shown), stimulation 
with an RGD peptide caused both BMX and STAT3 
recruitment to the detergent insoluble fraction 
(CSK+MSK) and hyperphosphorylation. Since both 
STAT3 and BMX exhibit similar redistribution and 
phosphorylation, these data and our in vivo 
observations showing a complex formation between 
BMX and STAT3 in PO myocardium strongly indicate 
that integrin-mediated BMX activation might serve as 
an upstream kinase for STAT3 activation in 
hypertrophying myocardium. 
  We therefore propose a novel mechanism of 
STAT3 activation during cardiac hypertrophy 
(summarized in Figure 6) where PO-induced integrin 
activation results in recruitment of several NTKs 
including BMX and STAT3 to the FAC. Subsequent 
activation of BMX can then mediate STAT3 
phosphorylation. Since STAT3 phosphorylation was 
observed in both the nucleus and MSK of 48 h PO 
myocardium, even while JAK2 was inactive, these 
findings strongly suggest that BMX-mediated STAT3 
activation not only contributes to cytoskeletal 
remodeling but also to the transcriptional activation in 
the nucleus. In this manner, STAT3 may control both 
FAC turnover for cytoskeletal remodeling and gene 
expression for cardioprotection during the early stages 
of cardiac hypertrophy.  
 
 
Figure 6. Proposed Mechanism of STAT3 Activation in Cardiac Hypertrophy. 
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